Neoadjuvant chemotherapy less commonly used in breast cancer

Published Date: 02 Mar 2023

Most women will have breast cancer surgery first if the initial consultation is with a surgeon. This study has been published as a preprint and has not yet been peer-reviewed.

Read Full News

Latest News

‘Impossible’ Now Possible: Making Brain Tissue Transparent

Researchers used a blood protein wash to render brain tissue transparent down to 700 µm, witnessing live-firing activity without killing a single neuron.

AstraZeneca's Imfinzi With Pre-surgery Drug Boosts Survival in Bladder Cancer Trial

AstraZeneca said on Thursday that a late-stage trial of Imfinzi, ⁠combined with a targeted therapy prior to a surgery, showed significantly ⁠improved survival rate in...

STS: Society of Thoracic Surgeons

Jehovah's Witnesses Transfusion Policy Now Allows Storage, Use of One's Own Blood

"I don't think it goes far enough, but it's a significant change," said one former member

Nobel-Winning Doctor Dies; 'Buffy' Star's Heart Defect; Cyberattack Delays Surgeries

Health news and commentary gathered by MedPage Today staff

Are We Missing Tumors When Using Antibiotics Alone for Appendicitis?

Study address key concern with nonoperative management of appendicitis

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

Researchers used a blood protein wash to render brain tissue transparent down to 700 µm, witnessing live-firing activity without killing a single neuron.

AstraZeneca said on Thursday that a late-stage trial of Imfinzi, ⁠combined with a targeted therapy prior to a surgery, showed significantly ⁠improved survival rate in...

"I don't think it goes far enough, but it's a significant change," said one former member

Health news and commentary gathered by MedPage Today staff

Study address key concern with nonoperative management of appendicitis

News All Time

UK and US Set Path to Shared Medical Device Approvals

The MHRA and FDA have agreed to explore mutual recognition of medical device approvals, in a move that could cut delays for patients in both countries.

They Say Compassion Drains You. Science Disagrees

Research suggests it’s not compassion that wears doctors down but a different emotion — a distinction that may help them recharge more effectively.

You Haven’t Aged a Day: The Prognostic Value of Facial Aging

An AI study suggests that the rate of facial aging could be a biomarker for cancer mortality.

Intraoperative Irradiation Safe for Breast Cancer Relapse

Intraoperative reirradiation in combination with a second breast-conserving surgery is safe and well tolerated in patients with late local recurrence of breast cancer.

Pancreatic Cancer: Should Surgery or Chemo Come First?

There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with operable pancreatic cancer. Here’s what we know.

Surgical Robots: NHS Ambition Outpacing Delivery

RCS England finds no national strategy for funding or distributing surgical robots, leaving some hospitals reliant on local fundraising.

NDAs Are Illegal in Healthcare, Says Ethicist

Ethicist Art Caplan discusses nondisclosure agreements in healthcare.

Whole-Body MRI Predicts Surgery Outcomes in Ovarian Cancer

Whole-body diffusion-weighted MRI accurately predicts complete resection and survival outcomes after neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

MRI Sharpens Prostate Cancer Risk Stratification

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.

Minimally Invasive Ablation Can Treat Small Kidney Tumors

Less invasive ablation treatment in patients with small renal tumors has a comparable risk for tumor progression to surgical resection, with fewer complications and shorter hospital stays.

177Lu-PSMA-617 Delays Progression in Prostate Cancer

177Lu-PSMA-617 delays disease progression at a significantly higher rate than standard of care in patients with oligometastatic hormone-sensitive prostate cancer.

Does ART Match ALND After Neoadjuvant Breast Cancer Therapy?

After neoadjuvant breast cancer treatment, axillary radiotherapy may offer an effective alternative to axillary lymph node dissection.

BC Rate Low in BRCA Carriers After Risk-Reducing Mastectomy

Researchers conduct a study of more than 1000 women with BRCA1 or BRCA2 mutations to compare breast cancer rates between those who do and do not undergo mastectomy.

Physalis minima (Golden Cherry)

Also known as golden cherry, Physalis minima is used often to treat inflammation, neurodegenerative disorders, and cancer in East Malaysian traditional medicine.

Should Doctors Strike to Limit AI Use at Work?

Some healthcare workers have been able to limit the role of AI in their work after going on strike. Is this a useful tactic for doctors?

Recommended News For You

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

Interleukin-6 may boost prediction of obesity-related cancers

Brain cancer: a Q&A session.

Global warming could be driving up women's cancer risk, find researchers

Toxic fungus from King Tutankhamun's tomb yields cancer-fighting compounds—new study

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

Telemedicine services linked to reducing excess mortality

Recommended Articles For You

The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management 

Unveiling the Complexity of Multiple Myeloma Staging 

New Research on Craniopharyngioma  

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

2.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

3.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

4.

Millions of men could benefit from faster scan to diagnose prostate cancer

5.

Team finds broken 'brake' on cancer mutation machine.

1.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

2.

Unravelling the Mysteries of Monoclonal Gammopathy

3.

Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment

4.

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management

5.

The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Oropharyngeal Cancer in Relation to HPV Status

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot